Document is current

Article History

Accepted: 10 May 2022

First Online: 13 June 2022

Declarations

:

: This study was sponsored by Pfizer and Eli Lilly & Company.

: Brett Hauber and Joseph Cappelleri are employees of and hold stock and/or stock options in Pfizer Inc. Marco Boeri is an employee of RTI Health Solutions, who were paid consultants to Pfizer and Eli Lilly & Company in connection with the development of this manuscript.

: The study was reviewed and deemed exempt by the RTI International Institutional Review Board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The research was carried out in compliance with national laws protecting respondents’ personal data.

: At the beginning of the survey, respondents were asked to explicitly give consent (electronically) to participate in the study. No clinical data were collected.

: The consent form included the use of data in an aggregated manner for publication.

: The datasets generated and analyzed during the current study are not available, although information can be obtained from the corresponding author (Marco Boeri) on reasonable request.

: The code is available on request from the corresponding author.

: MB and BH developed the survey instrument and collected the data with input from JC. MB executed the analysis. MB led the development of the manuscript, with input from BH and JC. All authors contributed to drafting and revising the manuscript, gave final approval for publication, and agree to be accountable for all aspects of the work.